摘要
慢性非传染病(简称慢病)是全球致死的重要原因,每年因慢病死亡的人数超过其他所有疾病导致死亡人数的总和。据估计,全球有63%的死亡源于慢病。在慢病死亡的人中,约有80%来自于低收入和中等收入国家。中国作为最大的发展中国家,拥有数量庞大的慢病患者和死于慢病的病例。在过去的20年里,中国和许多其他国家的慢病负担以惊人的速度增长。人群干预可以帮助减轻慢病负担,并具有较高的性价比,另外,改善医疗质量、早期诊断和及时治疗也可以减少慢病的影响。政府的坚定承诺和充足投入、各大社会体系和医疗系统的密切配合对减轻所有国家、特别是低收入和中等收入国家的慢病负担来说都非常重要。
Noncommunicable diseases(NCDs) are the leading causes of death globally,which kill more each year than all other causes combined.It is estimated that 63% of global total deaths were due to NCDs.Nearly 80% of NCD deaths occur in low-and middle-income countries.China contributes the largest number of NCD patients and deaths.NCD rates have been increasing at an alarming rate over the past two decades in China and many other countries.Population-wide interventions can help reduce NCD burden and can be cost effective.Improved health care,early detection and timely treatment are also needed for reducing the impact of NCDs.Strong government commitment,adequate investment,and extensive involvement and collaboration of multiple diverse social sectors with health sectors are critical to fight the NCD burden in all countries,especially in low-and middle-income countries.
出处
《北京大学学报(医学版)》
CAS
CSCD
北大核心
2012年第5期688-693,共6页
Journal of Peking University:Health Sciences
基金
Supported in part by a Center Grant from the Eunice Kennedy Shriver National Institute of Child Health&Human Development(U54HD070725)
关键词
慢性病
患病代价
中国
Chronic disease
Cost of illness
China